Clinical Trials Logo

Headache Disorders clinical trials

View clinical trials related to Headache Disorders.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06077747 Not yet recruiting - Chronic Headache Clinical Trials

Lumbar Vein Embolization for Chronic Headaches With Nutcracker Physiology

Start date: April 2024
Phase: N/A
Study type: Interventional

The purpose of this research is to gather information on the safety and feasibility of coiling the lumbar vein for the treatment of chronic headaches in patients with Nutcracker physiology and retrograde lumbar vein flow with epidural venous plexus congestion. All patients are extensively evaluated by a headache trained Neurologist confirming high pressure headache refractory to other treatments.

NCT ID: NCT05613582 Not yet recruiting - Clinical trials for Systemic Lupus Erythematosus

The Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus Erythematosus

SHADE
Start date: November 20, 2022
Phase: N/A
Study type: Interventional

The prevalence of chronic primary headache in Systemic Lupus Erythematosus (SLE) is 54.4%. Several studies have shown that the use of transcranial direct current stimulation (tDCS) at the primary motor cortex (M1), primary sensory cortex (S1), or dorsolateral prefrontal cortex (DLPFC) is effective as adjuvant therapy in primary headache. Using a double-blind design, this clinical trial study will investigate the effectiveness of tDCS as an adjuvant therapy in chronic daily headaches in SLE, by also comparing the effectiveness of administration in the M1, S1, and DLPFC. The primary endpoint that will be assessed is the frequency of headaches per week, with the secondary endpoints are the degree of headache, quality of life, sleep quality, level of depression, and use of analgesics.

NCT ID: NCT05334927 Not yet recruiting - Migraine Clinical Trials

China HeadAche DIsorders RegiStry

CHAIRS
Start date: August 29, 2022
Phase:
Study type: Observational [Patient Registry]

It is planned to include 10000 patients. In the China HeadAche DIsorders RegiStry CHAIRS), patients aged over 12 years with primary headache and medication-overuse headache(MOH) were collected. The biomarkers, imaging features, cognition, genetic characteristics, ocial and demographic data, medical data, therapeutics used, and outcome of headache-related diseases were studied, and long-term follow-up was planned.

NCT ID: NCT05213065 Not yet recruiting - Clinical trials for Post-Traumatic Headache

Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.

SPG
Start date: February 5, 2022
Phase: N/A
Study type: Interventional

Primary Objective The primary objective of the study is to assess whether transnasal sphenopalatine ganglion block using the device TX360 reduces intensity and severity of the Post-Traumatic Headache in adolescents. Secondary Objectives The study will also evaluate: - Quality of life (QoL) - Intensity of the headache - Physical function - Sleep quality - Role function (measured by PEDMIDAS) - Adverse events

NCT ID: NCT05057533 Not yet recruiting - Clinical trials for Primary Headache Disorder

Primary Headaches and Irritable Bowel Syndrome.

Start date: January 1, 2022
Phase:
Study type: Observational

To assess the relationship between primary headaches and irritable bowel syndrome

NCT ID: NCT04877561 Not yet recruiting - Headache Disorders Clinical Trials

Test-Retest Reliability of the German Version of the Headache Disability Questionnaire (HDQ).

Start date: June 1, 2021
Phase:
Study type: Observational

a translated and cultural adapted version of the HDQ will be tested on two occasions with headache patients who are currently in physiotherapeutic treatment due to their headache condition

NCT ID: NCT04352218 Not yet recruiting - Headache Clinical Trials

Safety Profile of PETALO CVS in the Treatment of Non-thrombotic Internal Jugular Vein Stenosis and Chronic Headache

PETALO
Start date: September 2020
Phase: Phase 2
Study type: Interventional

The purpose of the study is to assess, as first stage, the safety profile of an innovative venous- oriented device (Petalo CVS) in the treatment of patients with non-thrombotic internal jugular vein stenosis and chronic headache resistant to best medical therapy. After Stage 1, a second stage will be conducted to evaluate the preliminary efficacy.

NCT ID: NCT03632928 Not yet recruiting - Migraine Disorders Clinical Trials

Day to Day Variation of Pressure Pain Threshold and Muscle Hardness

Start date: September 2018
Phase:
Study type: Observational

The aim is to establish how headache and migraine can affect muscle hardness and tenderness in migraine patients

NCT ID: NCT00520156 Not yet recruiting - Clinical trials for Obstructive Sleep Apnea

Analysis of the Prevalence and Characteristics of Concomitant Sleep and Headache Disorders, and the Efficacy of CPAP Treatment for Headache Among Those Patients Diagnosed With Obstructive Sleep Apnea

Start date: August 2007
Phase: N/A
Study type: Observational

There is a well-documented but poorly understood relationship between headache disorders (e.g. migraine, cluster headaches, awakening headaches, etc.) and sleep disorders. One hypothesis includes an underlying disorder known as obstructive sleep apnea (OSA) with low overnight oxygen saturations and possibly elevated carbon dioxide levels which result in awakening headache. Bruxism, or grinding of the teeth, has also been anecdotally associated with headache. The converse of these arguments is that the patient may have a primary headache disorder, for example migraine, leading to disordered sleep patterns or insomnia. The true relationship between the two, as alluded above, is unknown. The actual prevalence of the two disorders occurring simultaneously is not known. There have been several small, retrospective studies which have attempted to evaluate this relationship. One of these studies evaluated those patients diagnosed with OSA who were given the standard of care therapy - continuous positive airway pressure (CPAP) - and found that headaches among these patients were improved after using CPAP. Again, this was a small, retrospective study. We propose a study whereby patients who are referred for polysomnography (PSG, or "sleep study") are consented, then surveyed on the presence or absence of headache. A brief questionnaire is followed up with a more detailed questionnaire to characterize whether this headache that the patient has is truly a headache disorder. Following the survey and PSG, the patient's sleep study parameters are evaluated to see whether there are certain correlations between what has been recorded and the particular headache disorder present. Lastly, if the patient was diagnosed with OSA and fitted with a CPAP device, the patient will be queried several weeks later to evaluate whether there was improvement or cessation of the headache disorder.